Wisconsin epilepsy research could help patients achieve seizure-free lives.

FDA approval of a new orally disintegrating tablet formulation offers patients greater treatment flexibility for chronic myeloid leukemia.

InnoCare's new drug application acceptance marks progress toward bringing a new treatment to patients.

FDA approves Hepcludex as the first-ever treatment for hepatitis D, offering hope to patients with limited options.

A new targeted cancer therapy receives priority review status, accelerating its path to patients in need.

A father celebrates his son's ability to access a new life-changing drug, bringing hope to families.

FDA approval of an innovative kidney stone treatment developed through biomedical engineering offers patients a new solution.

New medication for Tourette Syndrome shows promise in Phase III clinical trials.

The Miami CFAR Symposium showcases major breakthroughs in HIV treatment and cure research that are transforming the fight against the disease.

A novel nightly pill for sleep apnea has shown strong trial results and is being fast-tracked toward FDA approval.

First-ever weekly basal insulin approved by FDA simplifies diabetes management for patients.

Retatrutide clinical trial shows dramatic weight loss results, offering a promising new treatment option.

Vertex's pain relief drug suzetrigine advances with Health Canada review for treating moderate-to-severe acute pain.

Lilly's experimental weight loss drug shows significant results, helping patients lose substantial amounts of weight.

Five FDA first-in-class drug approvals in 2026 bring innovative new treatment mechanisms to patients.

Bayer's KERENDIA receives FDA priority review for treating kidney disease in adults with type 2 diabetes.

FDA approves a new blood pressure medication providing patients with an additional hypertension management option.

FDA approval of the first aldosterone synthase inhibitor provides a new treatment option for hypertension patients.

AstraZeneca's new blood pressure pill opens a new drug class for hypertension treatment.

AstraZeneca's blood pressure drug receives US approval, offering patients another treatment option.

Innovative cancer immunotherapy receives regulatory approval for clinical development.

First major stomach cancer drug approved for NHS use in a decade offers patients a significant therapeutic advance.

Regenxbio's positive new data brings hope closer to patients with Duchenne muscular dystrophy seeking gene therapy treatment.

FDA advances personalized, patient-centered care approaches offering more tailored treatment options.

FDA approval expands treatment options available to Alzheimer's disease patients.

A new blood pressure medication offers patients another therapeutic option.

Lilly's new obesity drug is so effective it's already being replicated by competitors.

FDA approves VEPPANU as an innovative new treatment option for patients.

First-in-state surgery successfully treats rare retinal disease using newly approved FDA therapy.

A new ALS drug successfully stabilizes decline and improves strength and mobility in some patients.

Repurposed cancer drugs show promising potential for treating Crohn's disease.

Regeneron commits to providing a new hearing-loss gene therapy at no cost to patients.

A discovery in joint fluid could transform how arthritis is treated and managed.

FDA approval of new HIV treatment provides patients with additional therapeutic options.

FDA approval of once-daily HIV treatment pill offers patients improved convenience and care options.

Dogwood Therapeutics receives FDA approval to advance its SP16 cancer program, moving closer to potential patient treatment.

A South African medical first uses liquid nitrogen breakthrough technology to successfully save a teenager's leg.

Four promising new drugs entering treatment options this spring could significantly transform patient care across multiple conditions.

Scientists discover a potential new cancer treatment, offering fresh therapeutic possibilities.

A promising new inflammatory bowel disease treatment shows encouraging results in early clinical trials.

A new daily pill shows promise in extending dogs' lifespans, offering hope for pet owners.

FDA clears testing of innovative CAR-T therapy for autoimmune diseases, opening new therapeutic possibilities.

A medical breakthrough helps a patient make remarkable progress in their Parkinson's disease recovery.

A breakthrough treatment offers renewed hope for Parkinson's patients after years of challenging disease progression.

Seven FDA-approved neurological treatments in early 2026 provide neurologists with powerful new therapeutic options.

FDA approval of a new oral GLP-1 pill offers patients another accessible weight loss treatment.

Eli Lilly's new weight-loss pill receives FDA approval, offering patients an additional therapeutic option for obesity management.

FDA approval of Eli Lilly's GLP-1 pill provides patients with a new oral option for effective weight loss treatment.

FibroBiologics successfully manufactures a promising drug candidate to treat diabetic foot ulcers.

FDA accepts priority review of new drug for rare developmental epilepsy, offering hope to affected families.

Mavacamten significantly reduces heart obstruction in teenagers with hypertrophic cardiomyopathy, offering new hope for young patients with this serious condition.

An experimental weight loss drug shows transformative potential for patients seeking new treatment options.

European regulatory committee recommends approval of Sanofi's Sarclisa and four additional new medications.

February FDA developments including kinase inhibitors, GLP-1 treatments, and new approval pathways represent important therapeutic advances.

FDA approves the first new Hunter Syndrome treatment in nearly two decades, offering hope to patients with this rare genetic disease.

Novel foam treatment successfully stops abdominal bleeding in clinical trials, offering hope for trauma patients.

FDA approval of a new endometriosis treatment provides relief options for millions of patients suffering from this painful condition.

FDA-approved Tecovirimat provides an effective treatment option for monkeypox infections.

New higher-dose Wegovy option gives patients more flexibility in managing their weight and health.